Wilkinson Walsh + Eskovitz Again Named “Boutique Firm of the Year” by Benchmark

wwe Homepage news, News, News

WASHINGTON, D.C. — Benchmark Litigation again named Wilkinson Walsh + Eskovitz the “Boutique Firm of the Year” during its annual awards ceremony in New York City — the second time in three years that WW+E has received the recognition. This prestigious award recognizes WW+E’s high-profile trial wins over the last year, including a defense verdict for the National Collegiate Athletic Association (NCAA) in McNair v. NCAA and multiple state-court bellwether trial victories for Bayer in trials involving the blood-thinner Xarelto. WW+E also achieved several other pre- and post-trial victories in 2018, including judgment granted as a matter of law to WW+E’s clients Oculus and Facebook on plaintiffs’ false designation claim in Zenimax Media et al. v. Oculus VR and complete dismissal, before any discovery, of a securities fraud class action case in In re MAXIMUS, Inc. Securities Litig. “We are deeply appreciative of Benchmark’s recognition of our firm for the second …

Litigation Daily: “Killer Crosses: How Wilkinson Walsh + Eskovitz Partners Shredded Witnesses in $600M Save for Bayer”

wwe Homepage news, News, News, Uncategorized

After the Wilkinson Walsh + Eskovitz team, led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin, won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers, Litigation Daily‘s Jenna Greene wrote about how Eskovitz and Walsh were “so good” at the cross-examinations that “the WW+E team called no defense witnesses. They annihilated the case on crosses alone”: If cross-examination is an art form, then Wilkinson Walsh + Eskovitz name partners Alexandra Walsh and Sean Eskovitz (pictured above) are masters. The duo led a trial team defending Bayer AG, which faced a $600 million certified consumer class action over its One A Day multivitamin. The plaintiffs alleged Bayer made false and misleading claims that One A Day supported heart health, immunity and physical energy. How good were the cross-examinations? So good that that the WW+E team called no defense witnesses. They annihilated the …

WW+E Secures Trial Win for Bayer in $600 Million One A Day Class Action

wwe Decisions, Homepage news, News, News, Uncategorized

WASHINGTON, D.C. — The Wilkinson Walsh + Eskovitz team, led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin, won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers.  Without calling any witnesses in the defense case, the team relied on devastating cross-examinations of plaintiffs’ expert and fact witnesses to convince the jury to reject plaintiffs’ claims that Bayer had misrepresented the health benefits of One A Day multivitamins.  The jury deliberated for just an hour before returning a complete defense verdict.  The class action suit, filed on behalf of purchasers of One A Day multivitamins in California, New York, and Florida, challenged as false and misleading Bayer’s claims that One A Day multivitamins support heart health, immunity, and physical energy. Plaintiffs originally sought over $4 billion in damages, which WW+E successfully reduced to $600 …

WW+E Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

wwe Homepage news, News, News

WASHINGTON – Wilkinson Walsh + Eskovitz is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of WW+E’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. WW+E won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, WW+E, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, WW+E, led by Kosta Stojilkovic and Rakesh …

Experienced Litigator Julie Rubenstein Promoted To WW+E Counsel

wwe Homepage news, News, News

WASHINGTON– Wilkinson Walsh + Eskovitz today announced that Julie Rubenstein has been promoted to Counsel effective January 1, 2019. Since joining WW+E as an associate, Rubenstein has used her breadth of experience representing corporate and individual clients to secure major victories for WW+E’s clients. Rubenstein most recently helped the NCAA obtain a defense jury verdict in a month-long defamation trial in Todd McNair v. NCAA. She led oral arguments on several key issues, including jury instructions, and she successfully defended against Plaintiff’s motion to compel. Her promotion is a testament to the firm’s investment in its next generation of leading attorneys and its emphasis on getting those attorneys into the courtroom. “Wilkinson Walsh + Eskovitz is a powerhouse firm because all attorneys – associates, counsel, and partners – are encouraged and empowered to contribute meaningfully to all aspects of our trial work,”said Ms. Rubenstein. “I am honored to work at …

Appeals Court Upholds Major Antitrust Win for WW+E Client Georgia Pacific

wwe Decisions, Homepage news, News, News

WASHINGTON,D.C. — The U.S. Court of Appeals for the Seventh Circuit unanimously upheld a major trial court win for Wilkinson Walsh + Eskovitz client Georgia Pacific, affirming the dismissal of a high stakes antitrust class action lawsuit involving over $10 billion in claimed damages. Georgia Pacific hired WW+E to handle all aspects of summary judgment briefing and trial after the trial court certified Plaintiffs’ proposed class. The WW+E team, led by Beth Wilkinson, Alexandra Walsh, Brant Bishop, and Rakesh Kilaru, developed an evidentiary record focused on the absence of any evidence against Georgia Pacific, and filed independent briefs challenging Plaintiffs’ expert witnesses and seeking summary judgment. In June 2017, the court issued a Daubert opinion that imposed key limits on the testimony Plaintiffs’ witnesses could offer at trial, adopting several of WW+E’s arguments. On August 3, 2017, WW+E won summary judgment for Georgia Pacific. The court’s decision came just one …

Wilkinson Walsh Secures Victory in Pro Bono Custody and Divorce Trial

wwe Decisions, Homepage news, News, News

Washington, D.C. — Following a six-day trial, Wilkinson Walsh + Eskovitz associates Cali Cope-Kasten and Hal Brewster secured a favorable judgment in a pro bono custody and divorce case in D.C. Superior Court.  The Court awarded WW+E’s client primary residential custody and joint legal custody, with tiebreaker decision making authority, of her five minor children.  The judge also found that WW+E’s client was entitled to an equitable lien on all major marital assets and awarded her a monetary judgment of more than a quarter-million dollars, along with ongoing child support that will help her establish financial independence in her new life. WW+E’s client separated from her husband in 2016 after multiple instances of abuse within the family.  After she filed for divorce, her estranged husband filed a countersuit in which he sought primary custody of their five children.  WW+E took on this pro bono representation as part of its ongoing …

WWE PARTNER ALEXANDRA WALSH NAMED LITIGATOR OF THE WEEK

wwe Homepage news, News, News

Award recognizes her role leading the Wilkinson, Walsh + Eskovitz team to another victory WASHINGTON – Litigation Daily selected Wilkinson Walsh + Eskovitz Founding Partner Alexandra Walsh as its Litigator of the Week for her role persuading a Philadelphia jury to find for the defense in a bellwether trial over the adequacy of the warning labels for the blood thinner Xarelto. Walsh, along with partners Tamarra Matthews Johnson and Rakesh Kilaru, won the third state-court bellwether trial over the blood- thinner Xarelto in the Pennsylvania Court of Common Pleas in August. The victory was the third win for Bayer in state court, and the sixth win overall, in the Xarelto litigation. Read her Q&A with Lit Daily Editor Jenna Greene here. Walsh and Johnson served as lead trial counsel for Bayer, and Kilaru helped direct the legal strategy. A 12-member jury in Philadelphia returned a defense verdict after less than …

WW+E Partners Secure Complete Dismissal of Securities Fraud Class Action

wwe Decisions, Homepage news, News, News

WASHINGTON – The WW+E Team, led by Founding Partners Brant Bishop and Beth Wilkinson and partner Kosta Stojilkovic, won complete dismissal of a securities fraud class action case in the Eastern District of Virginia for client MAXIMUS Inc.  In August 2017, MAXIMUS was sued under sections 10(b) and 20(a) of the Securities Exchange Act of 1934, based on allegations that the company, along with several members of its executive team, had made false or misleading statements on earnings calls and in SEC filings concerning MAXIMUS’s performance on a major contract with the British government. Led by Brant Bishop, WW+E moved to dismiss the amended complaint with prejudice, arguing that plaintiffs failed to plead facts giving rise to an inference that MAXIMUS acted with scienter, or an intent to defraud.  WW+E also argued that plaintiff failed to plead materiality as to certain alleged misstatements or omissions, and also failed to plead …

WW+E’s Kosta Stojilkovic, Kieran Gostin Named to Law360’s “Rising Stars”

wwe Homepage news, News, News, Uncategorized

WASHINGTON – Wilkinson Walsh + Eskovitz’s Kosta Stojilkovic and Kieran Gostin were named to Law360’s “Rising Stars of 2018,” an honor for “attorneys under 40 whose legal accomplishments transcend their age.” Kosta Stojilkovic was recognized for his trial work, while Kieran Gostin was recognized for his work on products liability matters. “Kosta and Kieran’s well-deserved recognition underscores our firm’s philosophy of empowering younger attorneys to showcase their talent, regardless of age or seniority,” said Wilkinson Walsh + Eskovitz Founding Partner Sean Eskovitz. “Kosta and Kieran are litigation superstars, bringing great intellect, judgment, and energy to everything they do, and we are proud that they are leading the way for the next generation of trial lawyers.“ Law360’s Rising Stars for 2018 were selected from over 1,200 submissions and are “based on their career accomplishments in their respective disciplines.” Most recently, Kosta obtained a complete defense verdict in McNair v. NCAA, a …